glp-1 for bulimia Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review GLP-1 drugs treat eating disorders

This data reportedly paints an upbeat picture about patients maintaining weight lossbut it is not peer-reviewed and was collected from a relatively small sample size of 109 customers over just six and a half months

GLP-1 RAs in MASH: Mechanisms of Action Although primarily used for the management diabetes and obesity, recent research indicates that GLP-1 RAs may also offer benefits to liver health

Hepatoprotective Effect of BPC 157, a 15-Amino Acid Peptide, on Liver Lesions Induced by Either Restraint Stress or Bile Duct and Hepatic Artery Ligation or CCl4 Administration

It activates the Wnt/-catenin pathway , a key biological switch that drives new follicle growth